Pathology of the prostate in radical cystectomy specimens: A critical review

被引:21
作者
Autorino, Riccardo [1 ]
Di Lorenzo, Giuseppe [2 ]
Damiano, Rocco [3 ]
Giannarini, Gianluca [4 ]
De Sio, Marco
Cheng, Liang [5 ]
Montironi, Rodolfo [6 ]
机构
[1] Univ Naples Federico II, Urol Clin, AOU Policlin, I-80138 Naples, Italy
[2] Univ Naples Federico II, Dipartimento Oncol Mol & Clin, Naples, Italy
[3] Magna Graecia Univ Catanzaro, UOC Urol, Catanzaro, Italy
[4] Univ Pisa, Dipartimento Urol, AOU Santa Chiara, I-56100 Pisa, Italy
[5] Indiana Univ, Dept Pathol & Lab Med, Sch Med, Indianapolis, IN USA
[6] Univ Politecn Marche, Sez Anat Patol, Ancona, Italy
来源
SURGICAL ONCOLOGY-OXFORD | 2009年 / 18卷 / 01期
关键词
Bladder cancer; Cystoprostatectomy; Pathology; Prostate cancer; Urothelial cancer; TRANSITIONAL-CELL-CARCINOMA; INVASIVE BLADDER-CANCER; UROTHELIAL CARCINOMA; CYSTOPROSTATECTOMY SPECIMENS; INTRAEPITHELIAL NEOPLASIA; CLINICAL-SIGNIFICANCE; CLINICOPATHOLOGICAL FEATURES; STROMAL INVASION; RISK-ASSESSMENT; ANTIGEN LEVELS;
D O I
10.1016/j.suronc.2008.07.006
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Our aim was to critically review clinico-pathological features of incidental prostate tumors in cystoprostatectomy specimens and to evaluate implications for patients' management. Data were identified by a structured MEDLINE search. Studies addressing incidence, pathological characteristics, and/or clinical significance of prostate tumors or related pre-malignant lesions from cystoprostatectomy series were reviewed in detail. The reported incidence of prostate adenocarcinoma in cystectomy specimens is highly variable and mostly depending on the histopathology technique of sampling. The clinical significance of these incidentally discovered cancers remains questionable, as the outcome of patients depends on the prognosis of the bladder tumor. For those candidates for prostate sparing surgery, it seems reasonable to include a routine prostate biopsy in the standard preoperative work-up as relevant PSA values to exclude cancer are lacking. Reports of prostatic urethral involvement at the time of radical cystectomy are mostly retrospective. Thus, it is likely that the true incidence of involvement with urothelial carcinoma is underreported. It has been suggested that multifocal bladder tumors, CIS in the bladder and bladder tumor location in the bladder neck are independent risk factors for prostatic urothelial carcinoma. Prostatic stromal involvement, which reflects the depth of invasion, is the most important prognostic factor. Poorly differentiated prostate adenocarcinoma and urothelial carcinoma often share overlapping morphologic features and it can be sometimes difficult to differentiate between these two entities. (C) 2008 Elsevier Ltd. All rights reserved.
引用
收藏
页码:73 / 84
页数:12
相关论文
共 80 条
[31]   Cancer statistics, 2007 [J].
Jemal, Ahmedin ;
Siegel, Rebecca ;
Ward, Elizabeth ;
Murray, Taylor ;
Xu, Jiaquan ;
Thun, Michael J. .
CA-A CANCER JOURNAL FOR CLINICIANS, 2007, 57 (01) :43-66
[32]   Risk assessment for occult malignancy in the prostate before radical cystectomy [J].
Kefer, JC ;
Voelzke, BB ;
Flanigan, RC ;
Wojcik, EM ;
Waters, WB ;
Campbell, SC .
UROLOGY, 2005, 66 (06) :1251-1255
[33]  
Kinoshita Yoshihisa, 2004, Clin Prostate Cancer, V3, P83, DOI 10.3816/CGC.2004.n.016
[34]   SIMULTANEOUS PRESENTATION OF ADENOCARCINOMA OF PROSTATE AND TRANSITIONAL CELL-CARCINOMA OF BLADDER [J].
KONSKI, A ;
RUBIN, P ;
DISANTANGNESE, PA ;
MAYER, E ;
KEYS, H ;
COCKETT, A ;
FRANK, I ;
DAVIS, R ;
LUSH, C .
UROLOGY, 1991, 37 (03) :202-206
[35]   Incidentally detected prostate cancer in cystoprostatectomy specimens [J].
Kouriefs, C ;
Fazili, T ;
Masood, S ;
Naseem, S ;
Mufti, R .
UROLOGIA INTERNATIONALIS, 2005, 75 (03) :213-216
[36]   Prostate-specific antigen, high-molecular-weight cytokeratin (Clone 34βE12), and/or p63 -: An optimal lmmunohistochemical panel to distinguish poorly differentiated prostate adenocarcinoma from urothelial carcinoma [J].
Kunju, LP ;
Mehra, R ;
Snyder, M ;
Shah, RB .
AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2006, 125 (05) :675-681
[37]   Comparative study on the prevalence of clinically detectable prostate cancer in patients with and without bladder cancer [J].
Kurokawa, K ;
Ito, K ;
Yamamoto, T ;
Takechi, H ;
Miyamoto, S ;
Suzuki, K ;
Yamanaka, H .
UROLOGY, 2004, 63 (02) :268-272
[38]   Synchronous primary carcinomas of the bladder and prostate [J].
Lee, SH ;
Chang, PL ;
Chen, SM ;
Sun, GH ;
Chen, CL ;
Shen, BY ;
Wu, YS ;
Tsui, KH .
ASIAN JOURNAL OF ANDROLOGY, 2006, 8 (03) :357-359
[39]   Urothelial carcinoma in the prostatic urethra and prostate:: current controversies [J].
Liedberg, Fredrik ;
Chebil, Gunilla ;
Mansson, Wiking .
EXPERT REVIEW OF ANTICANCER THERAPY, 2007, 7 (03) :383-390
[40]  
LISKOW AS, 1987, CANCER-AM CANCER SOC, V59, P380, DOI 10.1002/1097-0142(19870115)59:2<380::AID-CNCR2820590236>3.0.CO